跳至主要内容
临床试验/JPRN-UMIN000027561
JPRN-UMIN000027561已完成3 期

Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery:a randomized, double-blind, placebo-controlled trial - ProD Study

ational Cancer Center0 个研究点目标入组 220 人开始时间: 2017年6月4日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Drug abuse history including the stimulant drug 2.Delirium diagnosis with DSM-5 in registration 3.Kampo medication within 4 weeks ahead of registration 4.Medical history of serious drug allergy 5.Grade2 Hypokalemia or worse of CTCAE v4.0 within 8 weeks ahead of registration 6.Chemotherapy and/or radiotherapy planned within 1 week after surgery 7.Participation in other clinical trials, which use other medicine, within 3 months ahead of registration 8.Being judged as inadequate by physician

研究者

发起方
ational Cancer Center

相似试验